Bioqual Inc (BIOQ)
72.50
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Bioqual Net Income (Quarterly): 0.8995M for Aug. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
August 31, 2023 | 0.8995M |
Date | Value |
---|---|
August 31, 2022 | 1.384M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
0.8995M
Minimum
Aug 2023
1.384M
Maximum
Aug 2022
1.142M
Average
1.142M
Median
Net Income (Quarterly) Benchmarks
CEL-SCI Corp | -6.710M |
AIM ImmunoTech Inc | -12.58M |
IGC Pharma Inc | -5.589M |
NovaBay Pharmaceuticals Inc | -4.108M |
Protalix BioTherapeutics Inc | -6.044M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 15.58M |
Total Expenses (Quarterly) | 14.41M |
EPS Diluted (Quarterly) | 1.01 |
Enterprise Value | 58.41M |
Gross Profit Margin (Quarterly) | 19.41% |
Profit Margin (Quarterly) | 5.77% |